Clinical Trial Update: A Phase II Clinical Study to Evaluate HLX43 in Patients With Locally Advanced or Metastatic HCC Failed or Intolerance to Standard Therapy [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase II study evaluating HLX43 in patients with locally advanced or metastatic hepatocellular carcinoma who failed or were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• HLX43

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: RECRUITING